Charles Houston Jones
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.2MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 17, 2022 | NIH | SBIR Phase II DEVELOPMENT OF A LIPOSOMAL PNEUMOCOCCAL VACCINE FOR CLINICAL READINESS | $856K | Abcombi Biosciences Inc |
| Mar 16, 2021 | NIH | SBIR Phase II DEVELOPMENT OF A LIPOSOMAL PNEUMOCOCCAL VACCINE FOR CLINICAL READINESS | $940K | Abcombi Biosciences Inc |
| Apr 23, 2020 | NIH | SBIR Phase II DEVELOPMENT OF A LIPOSOMAL PNEUMOCOCCAL VACCINE FOR CLINICAL READINESS | $716K | Abcombi Biosciences Inc |
| Aug 2, 2018 | NIH | SBIR Phase I Lead Candidate Finalization and a Comprehensive Biological Assessment of a New Class of Pneumococcal Vaccines | $300K | Abcombi Biosciences Inc |
| Jan 17, 2017 | NIH | STTR Phase I Therapy for drug resistant influenza strains by nucleic acid targeting of respiratory airways | $50K | Abcombi Biosciences Inc |
| Jul 1, 2016 | NIH | STTR Phase I Therapy for drug resistant influenza strains by nucleic acid targeting of respiratory airways | $300K | Abcombi Biosciences Inc |
Peer ranks
Federal funding#567
Awards as PI#315
Patents#273
Companies
- Abcombi Biosciences IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.